Total syntheses of Tetrodotoxin and 9-epiTetrodotoxin

Peihao Chen, Jing Wang, Shuangfeng Zhang, Yan Wang, Yuze Sun, Songlin Bai, Qingcui Wu, Xinyu Cheng, Peng Cao, Xiangbing QiNature Communications 2024 · DOI

TL;DR

Researchers have developed a scalable, asymmetric synthesis of Tetrodotoxin (TTX) and its analog 9-epiTTX, starting from readily available furfuryl alcohol. This new route is significantly more efficient and scalable than previous methods, paving the way for larger quantities of TTX for potential therapeutic applications, particularly in pain management.

What Problem Does This Paper Address?

Tetrodotoxin (TTX) is a potent neurotoxin known for its remarkable anesthetic and analgesic properties, making it a promising candidate for pain treatment and detoxification therapies. However, its complex, highly oxygenated, and stereochemically dense structure has made its total synthesis a significant challenge. Previous syntheses, while groundbreaking, were often lengthy, low-yielding, and not amenable to producing TTX on a scale suitable for clinical applications. The need for a more efficient and scalable synthetic route has been a long-standing goal in organic chemistry.

Methods

The authors devised a novel synthetic strategy that begins with a stereoselective Diels-Alder reaction between furfuryl alcohol and maleic anhydride, facilitated by a chiral auxiliary, to rapidly construct the core oxygenated cyclohexane skeleton. Key innovative steps include:

  • Stereoselective Diels-Alder Reaction: This reaction, optimized to use isopropyl ether as a solvent, efficiently generates the optically pure bicyclic intermediate with high exo-selectivity, even on a large scale (>100 g).
  • Photoredox Decarboxylative Hydroxylation: A ruthenium-catalyzed reaction is employed to introduce an oxygen functionality at the C5 position, overcoming challenges with substrate decomposition under other conditions. This step was also optimized for flow chemistry.
  • SmI₂-Mediated Fragmentation and Reduction: A crucial sequence involving samarium diiodide (SmI₂) is used for concurrent fragmentation of an oxo-bridge, opening of the ring, and reduction of an ester, leading to a highly oxidized intermediate. This step was scaled up to decagram quantities.
  • Bridged Tetrahydrofuran Acetal Formation: The formation of a tetrahydrofuran acetal ring is highlighted as a critical step that reduces conformational flexibility, simplifying subsequent functional group manipulations and enabling a concise endgame.
  • Concise Endgame: The final stages involve oxidative cleavage of an alkyne, followed by guanidinylation and a one-pot formation of the cyclic guanidinium hemiaminal and orthoester, leading to TTX and its analogs.

Datasets

Not discussed in the paper. The study focuses on the synthesis and characterization of chemical compounds.

Key Insights and Ideas

  • Furfuryl Alcohol as a Starting Material: Utilizing an abundant and inexpensive feedstock like furfuryl alcohol significantly improves the practicality and scalability of TTX synthesis.
  • Diels-Alder for Core Construction: The early establishment of the stereochemically complex, oxygenated core via a Diels-Alder reaction is a powerful strategy for tackling highly functionalized natural products.
  • Flow Chemistry for Scale-Up: The successful adaptation of the photoredox decarboxylative hydroxylation to a circulating flow system demonstrates a commitment to scalable synthesis.
  • Conformational Control for Efficiency: The strategic formation of a bridged acetal to control molecular conformation is a clever approach to overcome challenges in late-stage functionalization.
  • Scalable Synthesis of TTX: The ability to produce TTX on a scale exceeding 15 mg (the largest previously reported) is a major advancement for potential therapeutic development.

Key Results

  • The total synthesis of Tetrodotoxin (TTX) was achieved in 24 steps.
  • The synthesis of 9-epiTetrodotoxin (9-epiTTX) was achieved in 22 steps.
  • The Diels-Alder reaction intermediate (+)-12 was prepared on a >100 g scale with high stereoselectivity.
  • The SmI₂-mediated sequence was successfully scaled to >10 g.
  • The synthetic TTX (TTX(S)) demonstrated comparable or superior blocking potency against Naᵥ1.7 channels compared to a commercial sample (TTX(C)), with IC₅₀ values of approximately 2.69 nM and 3.78 nM, respectively.
  • The synthesized TTX and 9-epiTTX were characterized and found to be identical to authentic reference samples.

Limitations and Future Work

  • Stereochemistry at C5: The initial decarboxylative hydroxylation at C5 resulted in an inverted configuration relative to TTX. The authors addressed this by employing a late-stage configurational inversion strategy, which they note simplifies the overall sequence.
  • Mixture of Products: The final deprotection step yielded a mixture of TTX and 4,9-anhydroTTX (1:1 ratio), which was then further processed. Similarly, 9-epiTTX was obtained as a mixture with its lactone form. While these mixtures were separable and characterized, the direct, single-product formation of TTX would be ideal.
  • Future Work: The authors suggest that this concise and scalable synthetic strategy is well-suited for the production of TTX congeners or derivatives for further pharmacological investigation and for large-scale synthesis of TTX for analgesic drug development, particularly for non-opioid cancer pain treatment. The potential for developing TTX for conditions beyond pain management is also implied.

Summary updated

Abstract

Tetrodotoxin and congeners are specific voltage-gated sodium channel blockers that exhibit remarkable anesthetic and analgesic effects. Here, we present a scalable asymmetric syntheses of Tetrodotoxin and 9-epiTetrodotoxin from the abundant chemical feedstock furfuryl alcohol. The optically pure cyclohexane skeleton is assembled via a stereoselective Diels-Alder reaction. The dense heteroatom substituents are established sequentially by a series of functional group interconversions on highly oxygenated cyclohexane frameworks, including a chemoselective cyclic anhydride opening, and a decarboxylative hydroxylation. An innovative SmI<sub>2</sub>-mediated concurrent fragmentation, an oxo-bridge ring opening and ester reduction followed by an Upjohn dihydroxylation deliver the highly oxidized skeleton. Ruthenium-catalyzed oxidative alkyne cleavage and formation of the hemiaminal and orthoester under acidic conditions enable the rapid assembly of Tetrodotoxin, anhydro-Tetrodotoxin, 9-epiTetrodotoxin, and 9-epi lactone-Tetrodotoxin.
BibTeX
@inproceedings{chen2024total,
  author = {Peihao Chen and Jing Wang and Shuangfeng Zhang and Yan Wang and Yuze Sun and Songlin Bai and Qingcui Wu and Xinyu Cheng and Peng Cao and Xiangbing Qi},
  title = {{Total syntheses of Tetrodotoxin and 9-epiTetrodotoxin}},
  booktitle = {Nature Communications},
  year = {2024},
  doi = {10.1038/s41467-024-45037-0},
}
Figure